Huaxia Eye Hospital Group Co. Ltd. A (301267) - Total Liabilities
Based on the latest financial reports, Huaxia Eye Hospital Group Co. Ltd. A (301267) has total liabilities worth CN¥2.11 Billion CNY (≈ $308.04 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Huaxia Eye Hospital Group Co. Ltd. A growing its equity to track the company's year-over-year net asset growth rate.
Huaxia Eye Hospital Group Co. Ltd. A - Total Liabilities Trend (2020–2024)
This chart illustrates how Huaxia Eye Hospital Group Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See Huaxia Eye Hospital Group Co. Ltd. A free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Huaxia Eye Hospital Group Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Huaxia Eye Hospital Group Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DANAOS CORP. DL -01
F:DVW1
|
Germany | €1.32 Billion |
|
Chang Wah Technology Co Ltd
TWO:6548
|
Taiwan | NT$11.37 Billion |
|
Runjian Communication Co Ltd Class A
SHE:002929
|
China | CN¥15.43 Billion |
|
Genting Bhd
KLSE:3182
|
Malaysia | RM52.02 Billion |
|
Polibeli Group Ltd Class A Ordinary Shares
NASDAQ:PLBL
|
USA | $5.14 Million |
|
Changshu Tianyin Electromechan
SHE:300342
|
China | CN¥512.19 Million |
|
Blackbaud Inc
NASDAQ:BLKB
|
USA | $2.31 Billion |
|
Eris Lifesciences Limited
NSE:ERIS
|
India | Rs36.56 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down Huaxia Eye Hospital Group Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Huaxia Eye Hospital Group Co. Ltd. A (301267) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Huaxia Eye Hospital Group Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Huaxia Eye Hospital Group Co. Ltd. A (2020–2024)
The table below shows the annual total liabilities of Huaxia Eye Hospital Group Co. Ltd. A from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.90 Billion ≈ $278.12 Million |
+14.41% |
| 2023-12-31 | CN¥1.66 Billion ≈ $243.08 Million |
+3.44% |
| 2022-12-31 | CN¥1.61 Billion ≈ $235.00 Million |
+17.12% |
| 2021-12-31 | CN¥1.37 Billion ≈ $200.65 Million |
+4.39% |
| 2020-12-31 | CN¥1.31 Billion ≈ $192.21 Million |
-- |
About Huaxia Eye Hospital Group Co. Ltd. A
Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis and treatment services for patients with ophthalmic diseases; and myopia prevention and intervention work to the public. It offers services in the areas of cataract, refraction, fundus, strabismus and amblyopia, pediatric ophthalmology, ocular … Read more